What is the interaction between amitriptyline and linezolid?

Amitriptyline and Linezolid: Serious Drug Interaction

The combination of amitriptyline and linezolid should be avoided due to the significant risk of serotonin syndrome, a potentially life-threatening condition. If concurrent use is absolutely necessary, it requires extremely close monitoring with immediate discontinuation at the first sign of symptoms.

Mechanism of Interaction

Linezolid functions as a reversible, nonselective monoamine oxidase inhibitor (MAOI) 1. When combined with serotonergic agents like tricyclic antidepressants (TCAs), including amitriptyline, this creates a dangerous pharmacological scenario:

• Linezolid inhibits monoamine oxidase type A, which normally breaks down serotonin
• Amitriptyline (a TCA) blocks serotonin reuptake at nerve terminals
• This dual mechanism causes excessive serotonin accumulation in the central nervous system 2

Clinical Manifestations of Serotonin Syndrome

Symptoms typically arise within 24-48 hours after combining these medications 2:

Early/Mild Symptoms:

• Mental status changes (confusion, agitation, anxiety)
• Tremors and restlessness

Moderate Symptoms:

• Neuromuscular hyperactivity (clonus, hyperreflexia, muscle rigidity)
• Autonomic hyperactivity (hypertension, tachycardia, tachypnea, diaphoresis, shivering)
• Vomiting and diarrhea

Severe/Life-Threatening:

• Hyperthermia and fever
• Seizures
• Cardiac arrhythmias
• Unconsciousness
• Death 2

A case report documented this exact interaction: a 68-year-old woman developed serotonin syndrome when receiving linezolid, amitriptyline, and fentanyl concurrently 3.

Management Recommendations

Primary Recommendation:

• Avoid this combination entirely 4
• Linezolid should generally not be administered to patients taking serotonergic agents like TCAs 4

If Combination is Unavoidable:

The British Thoracic Society guidelines explicitly state linezolid is contraindicated with MAOIs or within 2 weeks of discontinuing such agents, and caution is required with other serotonergic drugs 5. However, if clinical circumstances absolutely require concurrent use:

1. Obtain informed consent discussing the serious risks
2. Monitor continuously for the first 24-48 hours after initiation or dose changes
3. Watch for early warning signs: confusion, agitation, tremors, diaphoresis
4. Immediately discontinue both agents at first sign of serotonin syndrome
5. Hospitalize for supportive care with continuous cardiac monitoring if syndrome develops 2

Alternative Strategies:

• Consider stopping amitriptyline before starting linezolid (allow appropriate washout period)
• Use alternative antibiotics without MAOI activity if clinically feasible
• If depression/pain management is needed during linezolid therapy, consult psychiatry for non-serotonergic alternatives

Additional Linezolid Considerations

Beyond serotonin syndrome risk, linezolid requires monitoring for:

• Myelosuppression (weekly CBC for first 2 months) 5
• Peripheral neuropathy and optic neuritis (especially with prolonged use >2-4 weeks) 4, 5
• Drug interactions with other serotonergic agents (SSRIs, SNRIs, opioids like tramadol/meperidine, dextromethorphan) 2

Critical Pitfall

The FDA label explicitly warns about this interaction, noting that concurrent administration of linezolid with selective serotonin reuptake inhibitors or TCAs "can lead to serious reactions, such as serotonin syndrome or neuroleptic malignant syndrome-like reactions" 1. The interaction with amitriptyline specifically has been documented in case reports resulting in actual serotonin syndrome 3.

Bottom line: This is a contraindicated combination with documented mortality risk. Alternative therapeutic strategies should be pursued.